Performance During Menstrual Cycle

NCT ID: NCT03832972

Last Updated: 2022-05-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-10-01

Study Completion Date

2022-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This project aims to investigate if muscle strength and muscle power fluctuate during the menstrual cycle.

The hypothesis is that the greatest performance will be measured right before ovulation, and at it's lowest on day 1 and 2 of the menstrual cycle in women not using any form for hormonal protection.

And that the performance in women using birth control pills, not will variated in the period where they are taking pills (day 1-21).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Performance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Women using birth control

estrogen level

Intervention Type OTHER

Women are tested at different times in their menstrual cycle, if there is a cohesion between performance and level of estrogen

Women not using birthcontrol

estrogen level

Intervention Type OTHER

Women are tested at different times in their menstrual cycle, if there is a cohesion between performance and level of estrogen

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

estrogen level

Women are tested at different times in their menstrual cycle, if there is a cohesion between performance and level of estrogen

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Physical tests

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women
* 18-35 years of age
* BMI 18.5-25.

Exclusion Criteria

* Smoking
* hormonal or metabolic disorders
* chronic sickness
* use of medication
* breast feeding, vegetarians
* diet containing a lot of soja based products
* injuries which make it impossible to do the tests
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Team Denmark

OTHER

Sponsor Role collaborator

University of Aarhus

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Section of Sport Science

Aarhus, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

References

Explore related publications, articles, or registry entries linked to this study.

He W, Dam TV, Thogersen R, Hansen M, Bertram HC. Fluctuations in Metabolites and Bone Markers Across the Menstrual Cycle in Eumenorrheic Women and Oral Contraceptive Users. J Clin Endocrinol Metab. 2022 May 17;107(6):1577-1588. doi: 10.1210/clinem/dgac112.

Reference Type DERIVED
PMID: 35213728 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Estrogen2018

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Menstrual Cycle and Platelet-rich Fibrin
NCT06060574 NOT_YET_RECRUITING
Oral Contraceptive Therapy and Sexuality
NCT02613039 COMPLETED PHASE4